Atherosclerosis imaging and the future of lipid management

被引：12

作者：

Grundy, SM

机构：

[1] Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA

[3] Vet Affairs Med Ctr, Dallas, TX USA

来源：

CIRCULATION | 2004年 / 110卷 / 23期

关键词：

editorials; atherosclerosis; lipoproteins; statins; trials;

D O I：

10.1161/01.CIR.0000151100.28000.B3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3509 / 3511

页数：3

共 16 条

[1]

Bays Harold E, 2003, Prev Cardiol, V6, P179, DOI 10.1111/j.1520-037X.2003.03142.x

[2] Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans [J].

Bergman, AJ ;

Murphy, G ;

Burke, J ;

Zhao, JJ ;

Valesky, R ;

Liu, L ;

Lasseter, KC ;

He, WL ;

Prueksaritanont, T ;

Qiu, Y ;

Hartford, A ;

Vega, JM ;

Paolini, JE .

JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (09) :1054-1062

[3] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[4] REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].

BROWN, G ;

ALBERS, JJ ;

FISHER, LD ;

SCHAEFER, SM ;

LIN, JT ;

KAPLAN, C ;

ZHAO, XQ ;

BISSON, BD ;

FITZPATRICK, VF ;

DODGE, HT .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298

[5] Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].

Cannon, CP ;

Braunwald, E ;

McCabe, CH ;

Rader, DJ ;

Rouleau, JL ;

Belder, R ;

Joyal, SV ;

Hill, KA ;

Pfeffer, MA ;

Skene, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504

[6]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[7] Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial [J].

de Lemos, JA ;

Blazing, MA ;

Wiviott, SD ;

Lewis, EF ;

Fox, KAA ;

White, HD ;

Rouleau, JL ;

Pedersen, TR ;

Gardner, LH ;

Mukherjee, R ;

Ramsey, KE ;

Palmisano, J ;

Bilheimer, DW ;

Pfeffer, MA ;

Califf, RM ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1307-1316

[8] NICOTINIC-ACID AS THERAPY FOR DYSLIPIDEMIA IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].

GARG, A ;

GRUNDY, SM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (06) :723-726

[9] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, R ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Cleeman, JI ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ ;

Keller, SA ;

Jehle, AJ .

CIRCULATION, 2002, 106 (25) :3143-3421

[10] Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes - Results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial [J].

Grundy, SM ;

Vega, GL ;

McGovern, ME ;

Tulloch, BR ;

Kendall, DM ;

Fitz-Patrick, D ;

Ganda, OP ;

Rosenson, RS ;

Buse, JB ;

Robertson, DD ;

Sheehan, JP .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (14) :1568-1576

← 1 2 →